Related Experiment Video

Updated: Feb 7, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
06:47

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment

Published on: September 27, 2017

10.2K

Effects of GLP-1 Receptor Agonists on Major Cardiovascular Events Among Patients with Atopic Dermatitis: A

Abigail Katz1, Yvonne Nong2, Elaine J Ma3

  • 1From the, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Dermatitis : Contact, Atopic, Occupational, Drug
|February 6, 2026
PubMed

Insights

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) significantly reduced major adverse cardiovascular events in patients with atopic dermatitis. This study highlights GLP-1RA potential for managing cardiovascular risk in this population.

Area of Science:

  • Cardiology
  • Dermatology
  • Pharmacology

Background:

  • Atopic dermatitis (AD) is associated with elevated cardiovascular disease (CVD) risk.
  • Glucagon-like peptide-1 receptor agonists (GLP-1RAs) offer cardiometabolic benefits in the general population, but their effect in AD patients is not well-established.

Purpose of the Study:

  • To investigate the association between GLP-1RA use and the risk of major adverse cardiovascular events (MACE) in patients diagnosed with atopic dermatitis.

Main Methods:

  • A retrospective cohort study utilized the TriNetX Research Network.
  • Patients with AD (≥12 years) using GLP-1RAs were propensity-score matched (1:1) with non-users based on demographics and CVD risk factors.
  • The primary outcome was MACE incidence (CVD, heart failure, atherosclerosis, ischemic heart disease, PCI) assessed over 5, 10, and 20 years.

Main Results:

  • Among 547,246 AD patients, 4.6% used GLP-1RAs.
  • At 20 years, GLP-1RA use in AD patients was linked to lower odds of cerebrovascular disease (aOR 0.718), heart failure (aOR 0.791), atherosclerosis (aOR 0.768), and ischemic heart disease (aOR 0.900).

Conclusions:

  • GLP-1RA use in patients with atopic dermatitis is associated with a reduced long-term risk of major adverse cardiovascular events.
  • These findings suggest GLP-1RAs may provide significant cardiometabolic benefits for individuals with AD.

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.1K
Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V311:10

Genotypic Inference of HIV-1 Tropism Using Population-based Sequencing of V3

Published on: December 27, 2010

12.8K

Related Concept Videos

Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
984
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
4.1K
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists01:23

Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists

Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
1.0K
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
782
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...
374
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
512